Lenvatinib Mesylate Intermediate CAS 205448-65-3 Ubunyulu > 98.0% (HPLC) Factory
I-Ruifu Chemical Supply Lenvatinib Mesylate Intermediate with High Purity
Lenvatinib Mesylate CAS 857890-39-2
I-4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
I-Desquinolinyl Lenvatinib;I-1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
I-4-Amino-3-Chlorophenol CAS 17609-80-2
I-4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Igama leMchiza | I-Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate |
Izithethantonye | I-1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;ILenvatinib ePhakathi 3 |
Inombolo yeCAS | 205448-65-3 |
Inombolo yeCAT | RF-PI1973 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ye-50 MT / Year |
Ifomula yeemolekyuli | C12H11NO4 |
Ubunzima beMolekyuli | 233.22 |
Indawo yokubilisa | 421.0±45.0℃ |
Ukuxinana | 1.267±0.060 g/cm3 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | I-Off-White ukuya kwiPowder etyheli |
Ubunyulu / Indlela yokuHlalutya | >98.0% (HPLC) |
Ilahleko ekomisweni | <1.00% |
Intsalela kwi-Ignition | <0.50% |
Ukungcola ngokupheleleyo | <2.00% |
H-NMR | Iyahambelana noLwakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) iphakathi kweLenvatinib Mesylate (CAS: 857890-39-2).I-Lenvatinib, ethengiswa phantsi kwegama le-brand Lenvima phakathi kwabanye, liyeza elichasayo lomhlaza kunyango lweentlobo ezithile zomhlaza wegilo kunye neminye imihlaza ngokunjalo.Yaphuhliswa ngu-Eisai Co. kwaye isebenza njenge-multiple kinase inhibitor ngokuchasene ne-VEGFR1, VEGFR2 kunye ne-VEGFR3 kinases.I-Lenvatinib ivunyiwe (ukususela kwi-2015) yonyango lomhlaza we-thyroid owahlukileyo onokuthi ubuyele kwindawo okanye i-metastatic, i-progressive, kwaye ayizange iphendule unyango nge-iodine ye-radioactive (i-radioiodine).NgoMeyi ka-2016, i-US Food and Drug Administration (i-FDA) yavuma (ngokudityaniswa ne-everolimus) kunyango lwe-renal cell carcinoma ehamba phambili elandela unyango olunye lwangaphambili oluchasene ne-angiogenic.Iyeza likwavunyiwe e-US nakwiManyano yaseYurophu ye-hepatocellular carcinoma engenakususwa ngotyando kwizigulana ezingakhange zifumane unyango lomhlaza ngomlomo okanye ngenaliti.